928 EFFECTIVENESS OF TENOFOVIR DF (TDF) MONOTHERAPY IN PATIENTS WITH PRIOR EXPERIENCE TO NUCLEOSIDE/NUCLEOTIDE ANALOGUES BY DIFFERENT PATTERN OF PRE-EXISTING MUTATIONS von van Bömmel, F, deMan, R, Reijnders, J, Ferenci, P, Wedemeyer, H, Deterding, K, Bronowiki, J.P, Erhardt, A, Hüppe, D, Buggisch, P, Petersen, J, Bourlière, M, Schuchmann, M, Sarrazin, C, Trojan, J, Spengler, U, Brost, S, Rutter, K, Pariente, A, Wasmuth, H, Fülöp, B, Feucht, H.-H, Wiedenmann, B, Berg, T

Volltext

929 EVALUATION OF SAFETY AND TOLERABILITY OF TENOFOVIR DF (TDF) LONG TERM MONOTHERAPY IN NUCLEOS(T)IDE ANALOGUE EXPERIENCED PATIENTS WITH HBV MONOINFECTION von van Bömmel, F, deMan, R, Ferenci, P, Bronowiki, J.P, Wedemeyer, H, Erhardt, A, Hüppe, D, Bourlière, M, Sarrazin, C, Trojan, J, Buggisch, P, Petersen, J, Spengler, U, Brost, S, Schuchmann, M, Wasmuth, H, Reijnders, J, Deterding, K, Rutter, K, Fülöp, B, Feucht, H.-H, Wiedenmann, B, Berg, T

Volltext

HLA class II alleles and histological features in chronically infected HCV patients with consistently normal ALT levels von Renou, C., Halfon, P., Pol, S., Jouve, E., Bronowiki, J.P., Arpurt, J.P., Rifflet, H., Cacoub, P., Picon, M., Causse, X., Canva, V., Denis, J., Tran, A., Dantin, S., Bourliere, M., Ouzan, D., Pariente, A., Alric, L., Cartier, V., Reville, M., Caillat, S.

Volltext